Huiyang Yang

Title: Huiyang Yang - Innovator in Genetic Testing for Pouchitis Risk

Introduction

Huiyang Yang is a notable inventor based in Cerritos, CA (US). He has made significant contributions to the field of genetic testing, particularly in determining the risk of pouchitis development in patients with ulcerative colitis. His innovative approach has the potential to improve patient outcomes following surgical procedures.

Latest Patents

Huiyang Yang holds a patent for a method of determining the risk of pouchitis development. This invention provides a way to assess the presence or absence of a pouchitis-associated allele linked to an interferon γ receptor locus. The presence of this allele indicates an increased risk of pouchitis development, which can be crucial for patient management. The specific allele mentioned in his patent is located within the sixth intron of the interferon γ receptor 1 gene, such as the FA1 microsatellite 171 allele. This groundbreaking work has the potential to change how healthcare providers approach treatment for patients at risk.

Career Highlights

Huiyang Yang is affiliated with Cedars-Sinai Medical Center, where he continues to work on advancing medical research and innovation. His dedication to improving patient care through genetic testing exemplifies his commitment to the medical field. With 1 patent to his name, he stands out as a key figure in his area of expertise.

Collaborations

Huiyang Yang has collaborated with esteemed colleagues, including Kent D. Taylor and Jerome I. Rotter. These partnerships have likely contributed to the development and refinement of his innovative ideas.

Conclusion

Huiyang Yang's work in genetic testing for pouchitis risk represents a significant advancement in medical science. His contributions have the potential to enhance patient care and outcomes in the field of gastroenterology.